Neurogene (NGNE) Non Operating Interest Expenses (2013 - 2025)
Neurogene (NGNE) posted Non Operating Interest Expenses of $1,000 for Q4 2025, down 50.0% from $2,000 a year earlier and unchanged from the prior quarter.
Neurogene (NGNE) Non Operating Interest Expenses (2013 - 2025) Analysis & Trends
For FY2025, Neurogene's Non Operating Interest Expenses came in at $5,000, down 58.3% from FY2024.
- Annual Non Operating Interest Expenses shows a three-year compound annual growth rate of 35.7% (FY2022 to FY2025).
- In prior years, Neurogene's Non Operating Interest Expenses was $12,000 in FY2024 (unchanged), $12,000 in FY2023 (+500.0%) and $2,000 in FY2022.
- Quarterly Non Operating Interest Expenses has run from a low of $1,000 in Q2 2025 to a high of $4,000 in Q2 2024 over five years.
- On a year-over-year basis, Non Operating Interest Expenses has declined in each of the last six quarters, with an average decline of 25.0% over the last eight quarters.
- The strongest year-over-year quarter for Non Operating Interest Expenses in the past five years was Q1 2024, with growth of 50.0%; the weakest was Q2 2025, with a decline of 75.0%.
- According to Business Quant data, Non Operating Interest Expenses for the three prior quarters was $1,000 (Q3 2025), $1,000 (Q2 2025) and $2,000 (Q1 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Interest Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 217.00 Mn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | -477.00 Mn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 653.00 Mn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 269.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | - |
| 10 | Neurogene | 700.15 Mn | -397.16 Mn | - | - |
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 1,000.00 |
| Sep 30, 2025 | 1,000.00 |
| Jun 30, 2025 | 1,000.00 |
| Mar 31, 2025 | 2,000.00 |
| Dec 31, 2024 | 2,000.00 |
| Sep 30, 2024 | 3,000.00 |
| Jun 30, 2024 | 4,000.00 |
| Mar 31, 2024 | 3,000.00 |
| Dec 31, 2023 | 3,000.00 |
| Sep 30, 2023 | 4,000.00 |
| Jun 30, 2023 | 3,000.00 |
| Mar 31, 2023 | 2,000.00 |
| Dec 31, 2015 | -114,000.00 |
| Sep 30, 2015 | 4,000.00 |
| Jun 30, 2015 | 5,000.00 |
| Mar 31, 2015 | 6,000.00 |
| Dec 31, 2014 | -8,000.00 |
| Sep 30, 2014 | 2,000.00 |
| Jun 30, 2014 | 2,000.00 |
| Mar 31, 2014 | 454,000.00 |
Neurogene Non Operating Interest Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=NGNE&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-interest-expenses", "ticker": "NGNE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=NGNE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();